We transform the fight against cancer

Ontada is an oncology data science and technology business dedicated to improving the lives of cancer patients. We specialize in generating insights:

 

- Real-world data and evidence generation that accelerates life science research
- Clinical and operational technology that supports community providers with precise care
- Provider engagement channels that drive insights and support treatment educational programs

 

Deep roots in oncology


As a McKesson Corporation business, Ontada is part of a broader oncology ecosystem that includes an unmatched connection to The US Oncology Network, one of the largest independent oncology physician networks; US Oncology Research, a leader in clinical trial site management; Biologics by McKessonTM, a specialty pharmacy for oncology and other therapeutic areas; and Onmark® and Unity GPOs.

  • Leadership Team

    Meet the experts and innovators who have made it their mission to transform the fight against cancer.
    Susan Shiff, Ph.D.

    President

    Susan

    Shiff, Ph.D.

    Susan Shiff, Ph.D., is the president of Ontada where she leads the business in its vision of transforming the fight against cancer.

    Susan is a well-respected leader in real-world data insights and has more than 25 years of healthcare experience. Prior to joining Ontada in 2021, she served as senior vice president of Merck & Co, Inc., where she was head of their Center for Observational and Real-World Evidence. She also helped to define the investment strategy for the $500MM Merck Global Health Innovation Fund, including new ventures with digital health companies. Susan started her career with the Centers for Disease Control and Prevention and has worked for life science leaders including Johnson & Johnson, Roche and Pfizer.

    Susan holds an MBA from Cornell University and a Ph.D. from the University of California, Los Angeles. 

    Sarah Alwardt, Ph.D.

    Vice President, Operations

    Sarah

    Alwardt, Ph.D.

    Sarah Alwardt is the vice president of operations for Ontada. In this role, she is responsible for the day-to-day operations and delivery of the Market Insights, Advisory Solutions, and Real-World Research portfolios.

    Prior to joining McKesson, Sarah enjoyed ten years at Humana where she held leadership roles in research, program and process development. During her tenure, she reorganized and revitalized the research business, and facilitated strategic planning and the reengineering of the capital budgeting process for Humana Pharmacy Solutions. Sarah also held roles at Givaudan, Brown-Forman and the University of Louisville, where she served two years as adjunct professor of chemical engineering.

    Sarah is an accomplished author and speaker, having published and presented several works in rapid analytics and the importance of real-world data in oncology drug development. She holds multiple patents for her work on the removal of pesticides from citrus oils. In her current role, Sarah speaks frequently on the challenges and opportunities of real-world evidence and research collaboration between Fortune 100 companies.

    Sarah holds a bachelor’s, master’s and a doctoral degree in Chemical Engineering and a certificate in Environmental Engineering, all from the University of Louisville’s Speed School of Engineering.

    “Ontada has the power to revolutionize cancer care. From partnering with life science companies to understand gaps in care for early stage pharmaceuticals, to ensuring that trials are performed utilizing the most powerful advances in real-world research, to engaging providers and patients in the opportunities that will be created with new lifesaving medicines – we have the tools, technology and talent to deliver against these promises!”

    Steve Beier

    Vice President & General Manager, Oncology Technology Solutions

    Steve

    Beier

    Steve Beier is the vice president and general manager, Oncology Technology Solutions, which is focused on imagining, delivering, and evolving the emerging technologies fueling oncology care. He leads teams responsible for the end-to-end design, development, implementation, and support of Ontada’s technology products and McKesson’s Provider Oncology portfolio.

    Steve joined McKesson in 2018 to transform the Provider Technology Solutions organization. In this time, he has led a complete organizational transformation, including stabilizing the performance, improving the reliability of its premier EHR, iKnowMedSM Generation 2, and accelerating customer migration onto this platform. Under Steve’s leadership, the organization is focused on improving oncology patient outcomes through advances in Precision Medicine. This innovation is driving real-world advances in clinical trials, which enable biopharma to develop more effective oncology treatments faster than ever before.

    Before joining McKesson, Steve served as vice president of software development at Explorys, an IBM Watson Health company. He has over 20 years of professional experience in leadership roles at IBM, harnessing the analytical and computing power of the company to identify innovative technology opportunities and bring them to market.

    Steve holds a Master of Science in Technology Commercialization from the University of Texas at Austin and a Bachelor of Science in Cognitive Science from the University of California, San Diego. He studied Management Science and Engineering at Stanford University and also holds several patents in the areas of security for electronic product code (EPC) information services and supply chain management using mobile devices. Steve is passionate about building new businesses through transformation, innovation, and high-quality product delivery.

    Tina Page

    Vice President, Human Resources

    Tina

    Page

    Tina Page is the vice president of human resources for Ontada. In this role, she leads the human resources team and serves as an executive advisor to senior leadership. She is responsible for talent strategy, organization design, change management and culture, with a focus on inclusion and diversity.

    Tina has been with McKesson for 6-years and has served in multiple roles of increasing responsibility, most recently as the vice president of HR for The US Oncology Network. Previous to McKesson, Tina served in senior leadership roles with considerable expertise leading and shaping high-performance cultures for start-ups and top Fortune 500 corporations in diverse industries including REIT’s (real estate investment trusts), distribution operations with Amazon and in medical devices with Stryker. Her extensive and unique experience in executive leadership, business operations and innovation/process improvement have continuously driven impactful and value-driven results and legacies. Additionally, she serves as the executive sponsor of the employee resource group, PAVE (Pan-Asian Voices of Excellence), which focuses its efforts on providing professional development, fostering business excellence by harnessing strengths found in diverse backgrounds, building cultural awareness and engaging in community events.

    Tina holds a Bachelor of Arts degree in Communications with a minor in Business Management from the University of New Orleans.

    C. Lyn Fitzgerald

    Vice President, Sales

    C. Lyn

    Fitzgerald

    Lyn Fitzgerald is the vice president of sales for Ontada. She is responsible for building partnerships with life sciences companies to help advance innovation, improve outcomes and deliver quality oncology patient care. She oversees sales of Ontada’s full line of data research and commercial solutions, including Market Insights, Market Education, Advisory Solutions, and Real World Research.

    Prior to joining McKesson, Lyn spent more than 13 years at the National Comprehensive Cancer Network (NCCN), where she most recently served as senior vice president, U.S. & Global Development. During her tenure, Lyn drove the development and successful execution of an innovative business and significantly expanded the reach and utilization of NCCN content across the entire oncology ecosystem.

    Lyn holds a Bachelor of Business Administration and a Master of Jurisprudence in Communications, both from Temple University. She is a frequent national speaker on the role of guidelines in cancer care, a published author of several articles on health and healthcare policy, as well as a contributing author of multiple white papers and task force reports on quality, value, access, data and evidence-based care in oncology.

    “Ontada has the power to transform cancer care by providing life sciences companies and providers with the insights they need to bring new oncology drugs to market faster and realize true progress for patients. No other organization offers the essential insights of the largest provider network with embedded technology and enriched data sources.”

    Chris Frey

    Assistant General Counsel

    Chris

    Frey

    Chris Frey is the assistant general counsel, where she leads the legal team supporting Ontada’s customers, strategies and solutions.

    Previously, Chris was assistant general counsel for McKesson’s Prescription Technology Solutions. She also has experience in private practice at a large law firm focused on technology solutions, mergers & acquisitions and public-private partnerships.

    Chris holds a J.D. from the University of Michigan, where she graduated cum laude.

    “When Ontada succeeds, oncology patients and their care communities will experience unprecedented positive outcomes due to cutting-edge and affordable care driven by the power of data insights.”

    John Hopkins

    Vice President, Compliance & Ethics

    John

    Hopkins

    John Hopkins is the vice president of compliance & ethics for Ontada where he oversees operational compliance, ethics and privacy programs while helping balance the strategic business needs with regulatory and legal requirements.

    John joined McKesson in 2013 and has held numerous roles in policy governance, data privacy and compliance leadership in other McKesson technology service lines including Macro Helix and CoverMyMeds.

    Prior to McKesson, John worked for WebMD.com for more than 16 years where he helped define, build and oversee WebMD’s compliance & ethics programs for technology services and websites serving consumers, physicians and health plans. He started his life-long career in healthcare as a respiratory therapist in the U.S. Army. His last clinical role as a civilian was at the National Institutes of Health (NIH) in Bethesda, Maryland.

    John holds a Bachelor of Science degree in Communications from Kennesaw State University. 

    Matt Johnson

    Senior Vice President & Chief Financial Officer

    Matt

    Johnson

    Matt Johnson is the senior vice president and chief financial officer for Ontada. In this role, he leads the finance team for the growing business and his responsibilities include financial reporting and controls, financial planning and analysis, and managing investments in product growth, including mergers & acquisitions (M&A), identifying risk and managing the working capital investment.

    Matt has been at McKesson for 12 years and has served in roles of increasing responsibility throughout his tenure. Most recently, Matt was the senior vice president of corporate financial planning and analysis and M&A finance. Matt has also held finance director roles in both McKesson Europe and McKesson’s Pharmaceutical and Specialty Solutions businesses.

    Matt holds a Bachelor of Science in biochemistry from the University of Tennessee and an M.B.A. from Vanderbilt’s Owen School of Management.

    Derek Rago

    Senior Vice President, Strategic Initiatives

    Derek

    Rago

    Derek Rago is the senior vice president of strategic initiatives for Ontada where he leads the business in its vision of transforming the fight against cancer by creating actionable insights and intelligence throughout the spectrum of care.

    Derek joined McKesson in 2004 and has held a number of roles throughout his tenure. Most recently, he led McKesson’s Data, Evidence and Insights business, one of the core assets used to power Ontada. He also led the McKesson copay savings and patient adherence business, which is now part of RxCrossroads, a McKesson company.

    Prior to McKesson, Derek worked at what is now Symphony Health (a PRA Health Sciences company), where he played a key role in the creation and development of prescriber-level products that supported the pharmaceutical salesforce’s targeting and compensation efforts.

    Derek holds a Bachelor of Commerce from the University of Alberta and an MBA from Arizona State University.

    “My vision for cancer care when Ontada succeeds is that providers will have the right information at the right time in order to deliver personalized treatment plans for their patients. And Ontada will be the catalyst for life sciences companies advancing their innovative therapies so that they can be made available for patients at the center of the fight against cancer.”

  • Physician Leadership

    Meet the medical experts who play a key role in guiding our work.

    Dr. Marcus Neubauer

    Chief Medical Officer, The US Oncology Network

    Dr. Robert Coleman

    Chief Scientific Officer, US Oncology Research

    Dr. Loren
    Rourke

    Chief Surgical Officer, The US Oncology Network

    Dr. Vivek S. Kavadi

    Chief Radiation Oncology Officer, The US Oncology Network

    Dr. Nicholas Robert

    Medical Director, Oncology Research and Insights, Ontada

    Dr. Brian
    Heller

    Medical Director, Oncology Technology, Ontada

    Dr. Ira
    Zackon

    Medical Director, Oncology Research and Insights, Ontada